Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Feasibility study to compare three weight control programmes during adjuvant treatment for early breast cancer

Dates: 2008-2011
Funding: NHS Research for Patient Benefit programme
Collaborators: Wythenshawe Hospital, Manchester
Information: Jane Wolstenholme

A randomised controlled trial which had as its aim to determine whether individualized weight control programmes are better than standard written advice for existing weight and preventing weight gain in the first year after breast cancer treatment for women with early breast cancer. The trial compared a community-based programme, a home-based programme and a control group receiving standard written advice. HERC undertook a cost-effectiveness analysis alongside the trial.  Resource utilization in terms of health care, informal care and patient costs were routinely collected using patient diaries as an aide memoire.  Alongside disease-specific outcome measures, the EQ-5D was also being routinely administered.